Title:
DRUG COMPRISING LANTHANUM CARBONATE HYDRATE HAVING ADJUSTED PARTICLE SIZE
Document Type and Number:
WIPO Patent Application WO/2016/051609
Kind Code:
A1
Abstract:
This drug comprises a lanthanum carbonate hydrate which has a 90% cumulative diameter (D90) of 70μm or less and which is represented by La2(CO3)3⋅xH2O (in the formula, x represents a number 7-9). The drug does not have the problem of decreased product quality due to heat and moisture, and moreover allows quick and reliable removal of phosphates.
More Like This:
Inventors:
SATO TOMONORI (JP)
SUZUKI KENSUKE (JP)
SUZUKI KENSUKE (JP)
Application Number:
PCT/JP2014/080459
Publication Date:
April 07, 2016
Filing Date:
November 18, 2014
Export Citation:
Assignee:
TOWA PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K33/244; A61P3/12; A61P7/08
Foreign References:
US20110020456A1 | 2011-01-27 | |||
CN102432055A | 2012-05-02 | |||
CN102442692A | 2012-05-09 | |||
JP2012515723A | 2012-07-12 | |||
US20120219637A1 | 2012-08-30 | |||
US20130302383A1 | 2013-11-14 | |||
JPH11503119A | 1999-03-23 |
Other References:
HE ET AL.: "Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia", JOURNAL OF SPECTROSCOPY, vol. 2013, 15 October 2013 (2013-10-15), pages 1 - 6
SARBAJNA ET AL.: "Thermogravimetric Method Validation And Study Of Lanthanum Carbonate Octahydrate And Its Degradants", INTERNATIONAL JOURNAL OF CHEMTECH RESEARCH, vol. 5, no. 6, December 2013 (2013-12-01), pages 2810 - 2820
SARBAJNA ET AL.: "Thermogravimetric Method Validation And Study Of Lanthanum Carbonate Octahydrate And Its Degradants", INTERNATIONAL JOURNAL OF CHEMTECH RESEARCH, vol. 5, no. 6, December 2013 (2013-12-01), pages 2810 - 2820
Attorney, Agent or Firm:
Fukami Patent Office, p. c. (JP)
Patent business corporation Fukami patent firm (JP)
Patent business corporation Fukami patent firm (JP)
Download PDF: